GeneProof a.s.

01/05/2026

Tick season is here. Are you ready?

May marks and the start of peak tick activity in many regions worldwide.

As exposure increases, precise, reliable diagnostics play a critical role in supporting timely clinical decisions. PCR testing is recognized as a valuable confirmatory approach—delivering fast, dependable results when clarity matters most.

At GeneProof, we support laboratories with confident Lyme disease testing through the GeneProof™ Borrelia PCR Kit.

➡️ See how GeneProof helps laboratories stay prepared for tick season—learn more:

https://www.geneproof.com/geneprooftm-borrelia-pcr-kit/p1097

Note: Products are intended for in vitro diagnostic use by healthcare professionals only. Please reference the product instructions for use carefully prior to use.

27/04/2026

Dnes jsme u nás přivítali studenty z Mendelovy univerzity v Brně, kteří přišli nahlédnout do světa moderní molekulární diagnostiky a laboratorních technologií.

Během návštěvy jsme studentům představili:
✅ kdo jsme a čemu se věnujeme
✅ naše produkty a hlavní oblasti výzkumu
✅ zázemí tréninkového centra a používané přístroje
✅ praktickou ukázku platformy myCROBE®
✅ práci našich odborníků v laboratorním provozu

Studenti tak získali možnost vidět, jak se technologie využívají v reálné diagnostické praxi.

Děkujeme Ústavu chemie a biochemie MENDELU za návštěvu a kolegům za skvělou spolupráci! 🙌

23/04/2026

🚀 Hledáme Sales Managera pro ČR

Chcete rozvíjet obchod v oblasti molekulární diagnostiky a být součástí inovací, které mají reálný dopad na zdravotnictví? 🧬

💡 Hledáme energickou a obchodně orientovanou osobnost, která převezme odpovědnost za český trh, bude rozvíjet vztahy se zákazníky a aktivně vyhledávat nové příležitosti skrze úspěšná jednání a tendry.

Zní to jako vaše práce snů? Více informací se dozvíte na tomto linku:

👉https://www.geneproof.com/cs-cs/sales-manager-cz/t1218
📍 Brno + cestování po celé ČR

Jsme dynamická moderní biotechnologická společnost, která je globálním hráčem na poli molekulární in vitro diagnostiky. V dubnu 2022 se naše společnost spojila s americkou společností ALPCO, specializovanou na oblast imunologické diagnostiky. Toto strategické spojení představuje...

20/04/2026

myCROBE Summit 2026 | CZ & SK Edition

Last week, we had the pleasure of welcoming our Czech and Slovak customers to GeneProof HQ for a dedicated myCROBE-focused event.

Throughout the day, we explored the full potential of myCROBE™ – from live demonstrations and practical insights to open discussions about real laboratory needs and the future of molecular diagnostics. The program also included a session from Pronatal, where Mgr. Jana Mašínová, PhD. and Mgr. Kateřina Sedlářová shared their hands-on experience with myCROBE from routine laboratory practice.

🙏 We would like to thank them for their valuable co-presentation and for sharing their experience.

🤝 A rewarding day spent sharing knowledge, discussing approaches, and building stronger partnerships that move diagnostics forward.

💡 Curious about myCROBE? Learn more here:
https://www.geneproof.com/mycrobetm/p6666

15/04/2026

STI Awareness Week | Advancing Accurate and Efficient STI Diagnostics

During , we highlight the importance of comprehensive and reliable detection of sexually transmitted infections. We support clinical laboratories with one of the most extensive portfolios of fully automated PCR assays, designed to deliver flexibility without compromising diagnostic confidence.

Our à la carte multiplexing approach allows laboratories to test only what is clinically relevant for each sample—supporting efficient workflows and informed clinical decision-making.

GeneProof's Herpes Simplex Virus (HSV‑1/2) MC PCR Kit, the NEWEST addition to both our STI and IT myCROBE® portfolios, expands clinical utility with a wide range of validated specimen types.

Explore our full myCROBE STI portfolio: https://bit.ly/41lSmVY



𝘕𝘰𝘵𝘦: 𝘗𝘳𝘰𝘥𝘶𝘤𝘵𝘴 𝘢𝘳𝘦 𝘪𝘯𝘵𝘦𝘯𝘥𝘦𝘥 𝘧𝘰𝘳 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤 𝘶𝘴𝘦 𝘣𝘺 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴 𝘰𝘯𝘭𝘺. 𝘗𝘭𝘦𝘢𝘴𝘦 𝘳𝘦𝘧𝘦𝘳𝘦𝘯𝘤𝘦 𝘵𝘩𝘦 𝘱𝘳𝘰𝘥𝘶𝘤𝘵 𝘪𝘯𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘶𝘴𝘦 𝘤𝘢𝘳𝘦𝘧𝘶𝘭𝘭𝘺 𝘱𝘳𝘪𝘰𝘳 𝘵𝘰 𝘶𝘴𝘦.

07/04/2026

Správná laboratorní praxe GP

Naše jarní kurzy odstartovaly a hned první termín přinesl spoustu cenných poznatků a praktických zkušeností! 🔬 Účastníci měli možnost detailně se seznámit s technickými parametry našich GP kitů a vyzkoušet si izolaci nukleových kyselin i práci s PCR. Sdílení zkušeností mezi odborníky z různých klinických pracovišť bylo skvělým přínosem.

Děkujeme a těšíme se na další setkání! 😊

03/04/2026

🧪 A milestone in transplant diagnostics.

Our Cytomegalovirus (CMV) MC PCR Kit is now IVDR-compliant and available on the myCROBE™ fully automated platform — completing a comprehensive Immunocompromised/Transplant (IT) assay menu for clinical laboratories across Europe.

“This menu expansion strengthens our ability to support laboratories managing complex infections in transplant settings, where rapid and accurate pathogen detection is essential for patient management.” Erik Allen, CEO, NuvinkaDx

myCROBE now enables simultaneous detection of key IT viruses, including Cytomegalovirus, Epstein–Barr virus, Human Herpesvirus 6/7, Human Herpesvirus 8, Varicella-zoster virus, Herpes Simplex virus 1/2, BK virus, and JC virus.

Link to press release: https://bit.ly/4c0jheD

31/03/2026

GeneProof & ALPCO are coming to ESCMID 2026 — see you in April!

GeneProof and ALPCO, part of the family NuvinkaDx, are heading to ESCMID 2026 in Munich to showcase their molecular and immunodiagnostic expertise. Come see how we’re helping laboratories deliver faster, reliable, and high-quality results.

At our booth, you’ll be able to:
🔬 Discover our latest PCR and immunodiagnostic solutions
🎥 See a live DEMO of myCROBE™ on Sunday, 19 April from 1-2 pm
🤝 Connect with our team and explore collaboration opportunities
🌍 Exchange ideas on emerging trends in laboratory diagnostics

📍 Messe Munich Exhibition & Congress Center | Booth D92, Hall B1
📅 April 18–21, 2026

Don’t miss this chance to meet us in person — let’s discuss how we can support your lab’s goals.

👉 Schedule a meeting with our Export Manager here: https://www.geneproof.com/escmid/t1282

30/03/2026

Expand your PCR testing portfolio

GeneProof’s myCROBE™ PCR portfolio already includes Thrombotic Mutations and STIs, and now introduces the Immunocompromised / Transplant (IT) testing portfolio – designed for monitoring of immunocompromised patients.

Tailored to laboratory:
✅Supports viral load monitoring of immunocompromised patients, particularly after solid organ (SOT) and hematopoietic stem cell transplantation (HSCT)
✅Designed in line with european guidelines
✅Delivers reliable results from just 250 µL of whole blood
✅Enables testing of high-risk populations, including pediatric and transplant patients
✅All myCROBE™ assays are CE IVD, including the CMV MC PCR Kit already IVDR, ensuring compliance and confidence

🔗 Discover Our Assays: https://www.geneproof.com/mycrobetm/p6666



Note: Products are intended for in vitro diagnostic use by healthcare professionals only. Please reference the product instructions for use carefully prior to use.

26/03/2026

🧬 myCROBE Summit 2026

This week, distributors from across the globe are visiting us at GeneProof HQ for a two-day deep dive into everything myCROBE has to offer. 🌍🔬

From live product demos and an R&D inside look to a regulatory landscape update and a featured guest speaker — it's the kind of event where real conversations happen and partnerships get stronger.

💡 Want to know more about myCROBE? Visit our website: https://www.geneproof.com/mycrobetm/p6666

Note: Products are intended for in vitro diagnostic use by healthcare professionals only. Please reference the product instructions for use carefully prior to use.

24/03/2026

🌍 On World TB Day, we come together to raise awareness of the global effort to eliminate tuberculosis and support advancements in early and accurate diagnostics.

The GeneProof Mycobacterium tuberculosis PCR Kit provides fast, reliable and sensitive detection, helping clinicians make timely decisions 🔬 in the diagnosis and management of TB.

Together, we can continue moving toward a future ✨ where tuberculosis is no longer a threat.

Note: Products are intended for in vitro diagnostic use by healthcare professionals only. Please reference the product instructions for use carefully prior to use.